Manulife (Manufacturers Life Insurance)’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,329
| Closed | -$220K | – | 3315 |
|
|
2021
Q2 | $220K | Sell |
1,329
-71,092
| -98% | -$11.9M | ﹤0.01% | 3043 |
|
|
2021
Q1 | $11.1M | Sell |
72,421
-91,718
| -56% | -$12.5M | 0.01% | 907 |
|
|
2020
Q4 | $20.6M | Buy |
164,139
+1,681
| +1% | +$188K | 0.02% | 589 |
|
|
2020
Q3 | $16.5M | Sell |
162,458
-4,829
| -3% | -$492K | 0.02% | 604 |
|
|
2020
Q2 | $15.7M | Sell |
167,287
-5,394
| -3% | -$502K | 0.01% | 608 |
|
|
2020
Q1 | $14.3M | Buy |
172,681
+2,362
| +1% | +$230K | 0.02% | 591 |
|
|
2019
Q4 | $18.9M | Sell |
170,319
-7,159
| -4% | -$736K | 0.02% | 574 |
|
|
2019
Q3 | $17.5M | Buy |
177,478
+7,917
| +5% | +$786K | 0.02% | 599 |
|
|
2019
Q2 | $16.8M | Buy |
169,561
+73,226
| +76% | +$6.99M | 0.02% | 613 |
|
|
2019
Q1 | $10.6M | Sell |
96,335
-2,266
| -2% | -$237K | 0.01% | 826 |
|
|
2018
Q4 | $9.07M | Buy |
98,601
+2,443
| +3% | +$247K | 0.01% | 846 |
|
|
2018
Q3 | $10.6M | Buy |
96,158
+15,098
| +19% | +$1.57M | 0.01% | 847 |
|
|
2018
Q2 | $7.57M | Buy |
81,060
+43,882
| +118% | +$3.78M | 0.01% | 1052 |
|
|
2018
Q1 | $3.08M | Sell |
37,178
-743
| -2% | -$66K | ﹤0.01% | 1368 |
|
|
2017
Q4 | $3.45M | Buy |
37,921
+713
| +2% | +$59.3K | ﹤0.01% | 1326 |
|
|
2017
Q3 | $2.83M | Buy |
37,208
+6,655
| +22% | +$503K | ﹤0.01% | 1338 |
|
|
2017
Q2 | $2.29M | Buy |
30,553
+11,057
| +57% | +$767K | ﹤0.01% | 1405 |
|
|
2017
Q1 | $1.27M | Buy |
19,496
+2,185
| +13% | +$129K | ﹤0.01% | 1621 |
|
|
2016
Q4 | $954K | Sell |
17,311
-32
| -0.2% | -$1.76K | ﹤0.01% | 1694 |
|
|
2016
Q3 | $980K | Buy |
17,343
+78
| +0.5% | +$3.83K | ﹤0.01% | 1658 |
|
|
2016
Q2 | $721K | Buy |
17,265
+2,977
| +21% | +$137K | ﹤0.01% | 1802 |
|
|
2016
Q1 | $608K | Sell |
14,288
-20
| -0.1% | -$845 | ﹤0.01% | 1872 |
|
|
2015
Q4 | $648 | Buy |
14,308
+137
| +1% | +$5.76K | ﹤0.01% | 1862 |
|
|
2015
Q3 | $551 | Buy |
14,171
+333
| +2% | +$13.3K | ﹤0.01% | 1931 |
|
|
2015
Q2 | $503 | Buy |
13,838
+1,398
| +11% | +$44.2K | ﹤0.01% | 2114 |
|
|
2015
Q1 | $358 | Buy |
12,440
+7,885
| +173% | +$220K | ﹤0.01% | 2302 |
|
|
2014
Q4 | $110 | Buy |
+4,555
| New | +$103K | ﹤0.01% | 3040 |
|
Other funds holding PRAH
Manulife (Manufacturers Life Insurance)'s PRAH Position: Q3 2021 in Review
Manulife (Manufacturers Life Insurance) sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,329 shares — an estimated $220K sold.
Manulife (Manufacturers Life Insurance) first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $20.6M in Q4 2020. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Manulife (Manufacturers Life Insurance) reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 1,329 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $220K.
- Manulife (Manufacturers Life Insurance) first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- Manulife (Manufacturers Life Insurance)'s PRA Health Sciences, Inc. position peaked at $20.6M in Q4 2020.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2021, filed 12 Nov 2021.